James Goodhand

4.8k total citations
75 papers, 1.5k citations indexed

About

James Goodhand is a scholar working on Genetics, Epidemiology and Surgery. According to data from OpenAlex, James Goodhand has authored 75 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Genetics, 28 papers in Epidemiology and 20 papers in Surgery. Recurrent topics in James Goodhand's work include Inflammatory Bowel Disease (41 papers), Microscopic Colitis (26 papers) and Chronic Lymphocytic Leukemia Research (8 papers). James Goodhand is often cited by papers focused on Inflammatory Bowel Disease (41 papers), Microscopic Colitis (26 papers) and Chronic Lymphocytic Leukemia Research (8 papers). James Goodhand collaborates with scholars based in United Kingdom, United States and Australia. James Goodhand's co-authors include David S. Rampton, Mahmood Wahed, James O. Lindsay, Nicholas M. Croft, William Alazawi, A D Farmer, Joel Mawdsley, Qasim Aziz, Tariq Ahmad and Nicholas A. Kennedy and has published in prestigious journals such as Gastroenterology, Gut and BMJ.

In The Last Decade

James Goodhand

68 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
James Goodhand United Kingdom 20 753 687 411 243 233 75 1.5k
Shehzad A. Saeed United States 24 613 0.8× 446 0.6× 605 1.5× 448 1.8× 287 1.2× 79 1.9k
Garret Cullen Ireland 22 738 1.0× 674 1.0× 438 1.1× 90 0.4× 157 0.7× 55 1.6k
Jingdong Chao United States 30 1.9k 2.5× 1.7k 2.4× 707 1.7× 115 0.5× 169 0.7× 146 3.5k
Mariëlle Romberg‐Camps Netherlands 24 1.4k 1.9× 1.1k 1.6× 603 1.5× 61 0.3× 140 0.6× 68 2.0k
Christian P. Selinger United Kingdom 31 1.4k 1.9× 946 1.4× 1.1k 2.8× 187 0.8× 339 1.5× 146 2.9k
Stéphane Nahon France 21 977 1.3× 885 1.3× 645 1.6× 65 0.3× 329 1.4× 91 1.7k
Nancy Williams United Kingdom 7 1.3k 1.7× 1.1k 1.6× 515 1.3× 124 0.5× 186 0.8× 9 1.8k
Magne Henriksen Norway 21 2.3k 3.0× 2.0k 2.9× 939 2.3× 73 0.3× 260 1.1× 31 2.8k
Dan Ollendorf United States 6 455 0.6× 373 0.5× 258 0.6× 89 0.4× 58 0.2× 8 1.0k
Andrew Tinsley United States 16 527 0.7× 410 0.6× 248 0.6× 53 0.2× 113 0.5× 62 919

Countries citing papers authored by James Goodhand

Since Specialization
Citations

This map shows the geographic impact of James Goodhand's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James Goodhand with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James Goodhand more than expected).

Fields of papers citing papers by James Goodhand

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James Goodhand. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James Goodhand. The network helps show where James Goodhand may publish in the future.

Co-authorship network of co-authors of James Goodhand

This figure shows the co-authorship network connecting the top 25 collaborators of James Goodhand. A scholar is included among the top collaborators of James Goodhand based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James Goodhand. James Goodhand is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Plevris, Nikolas, Beatriz Gros, James Goodhand, et al.. (2024). P823 Real-world effectiveness of upadacitinib in Crohn's disease; a UK multicentre retrospective cohort study. Journal of Crohn s and Colitis. 18(Supplement_1). i1523–i1525.
2.
Verstockt, Bram, Valerie Pivorunas, Naim Al Mahi, et al.. (2023). Baseline TREM-1 Whole Blood Gene Expression Does Not Predict Response to Adalimumab Treatment in Patients with Ulcerative Colitis or Crohn’s Disease in the SERENE Studies. Journal of Crohn s and Colitis. 18(4). 493–505. 3 indexed citations
3.
Lin, Simeng, Eilís Hannon, Mark Reppell, et al.. (2023). Whole Blood DNA Methylation Changes Are Associated with Anti-TNF Drug Concentration in Patients with Crohn’s Disease. Journal of Crohn s and Colitis. 18(8). 1190–1201. 7 indexed citations
4.
Chanchlani, Neil, Simeng Lin, Rachel Nice, et al.. (2023). Pretreatment Vitamin D Concentrations Do Not Predict Therapeutic Outcome to Anti-TNF Therapies in Biologic-Naïve Patients With Active Luminal Crohn’s Disease. Crohn s & Colitis 360. 5(3). otad026–otad026. 5 indexed citations
5.
Alexander, James L., Zhigang Liu, Hajir Ibraheim, et al.. (2023). P75 Vaccine-induced antibody responses against influenza are diminished in infliximab and tofacitinib-treated IBD patients and correlate with responses to COVID-19 vaccination. Poster presentations. A88.1–A88. 1 indexed citations
6.
7.
Chanchlani, Neil, Simeng Lin, Benjamin Hamilton, et al.. (2021). HMO-4 Immunogenicity to second anti-TNF therapy (IMSAT): implications for sequencing of biologic therapy. A31.2–A32.
8.
Hamilton, Benjamin, Harry Green, Neel Heerasing, et al.. (2020). Incidence and prevalence of inflammatory bowel disease in Devon, UK. Frontline Gastroenterology. 12(6). 461–470. 18 indexed citations
9.
Walker, G, Neil Chanchlani, Amanda Thomas, et al.. (2020). Primary care faecal calprotectin testing in children with suspected inflammatory bowel disease: a diagnostic accuracy study. Archives of Disease in Childhood. 105(10). 957–963. 5 indexed citations
10.
Walker, G, Simeng Lin, Neil Chanchlani, et al.. (2020). Quality improvement project identifies factors associated with delay in IBD diagnosis. Alimentary Pharmacology & Therapeutics. 52(3). 471–480. 20 indexed citations
11.
Chee, Desmond, Benjamin Hamilton, Neel Heerasing, et al.. (2020). Root‐cause analyses of missed opportunities for the diagnosis of colorectal cancer in patients with inflammatory bowel disease. Alimentary Pharmacology & Therapeutics. 53(2). 291–301. 16 indexed citations
12.
Nice, Rachel, Neil Chanchlani, Harry Green, et al.. (2020). Validating the positivity thresholds of drug‐tolerant anti‐infliximab and anti‐adalimumab antibody assays. Alimentary Pharmacology & Therapeutics. 53(1). 128–137. 10 indexed citations
13.
Green, Harry, Robin N. Beaumont, Amanda Thomas, et al.. (2019). Genome-Wide Association Study of Microscopic Colitis in the UK Biobank Confirms Immune-Related Pathogenesis. Journal of Crohn s and Colitis. 13(12). 1578–1582. 31 indexed citations
14.
15.
Mikocka‐Walus, Antonina, Jane M. Andrews, Çharles N. Bernstein, et al.. (2012). Integrated Models of Care in Managing Inflammatory Bowel Disease: A Discussion. Inflammatory Bowel Diseases. 18(8). 1582–1587. 57 indexed citations
16.
García-Hernández, Jorge, et al.. (2012). PMO-023 Assessment of quality of life, coping strategies and personal beliefs in neuroendocrine tumour patients. Gut. 61(Suppl 2). A82.2–A82. 2 indexed citations
17.
Wahed, Mahmood, James Goodhand, Louise Langmead, et al.. (2011). Anxiety and psychological stress in acute severe ulcerative colitis: prevalence and effect on outcome. Gut. 60(Suppl 1). A222.1–A222. 1 indexed citations
18.
Goodhand, James, William Alazawi, & David S. Rampton. (2011). Systematic review: clostridium difficile and IBD. Gut. 60(Suppl 1). A146.1–A146. 2 indexed citations
19.
20.
Kamperidis, Nikolaos, et al.. (2011). P82 Haemoglobin level prior to liver transplantation: does it predict the outcome?: Abstract P82 Figure 1. Gut. 60(Suppl 2). A38.1–A38. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shehzad A. Saeed Breakdown of academic impact, for papers by Garret Cullen Breakdown of academic impact, for papers by Jingdong Chao Breakdown of academic impact, for papers by Mariëlle Romberg‐Camps Breakdown of academic impact, for papers by Christian P. Selinger Breakdown of academic impact, for papers by Stéphane Nahon Breakdown of academic impact, for papers by Nancy Williams Breakdown of academic impact, for papers by Magne Henriksen Breakdown of academic impact, for papers by Dan Ollendorf Breakdown of academic impact, for papers by Andrew Tinsley
Rankless by CCL
2026